A Minor Subset of Super Elongation Complexes Plays a Predominant Role in Reversing HIV-1 Latency

Authors:
Publisher website
Google Scholar
Abstract
Promoter-proximal pausing by RNA polymerase (Pol) II is a key rate-limiting step in HIV-1 transcription and latency reversal. The viral Tat protein recruits human Super Elongation Complexes (SECs) to paused Pol II to overcome this restriction. Despite the recent progress in understanding the functions of different subsets of SECs in controlling cellular and Tat-activated HIV transcription, little is known about the SEC subtypes that help reverse viral latency in CD4+ T cells. Here, we used the CRISPR-Cas9 genome-editing tool to knock out the gene encoding the SEC subunit ELL2, AFF1, or AFF4 in Jurkat/2D10 cells, a well-characterized HIV-1 latency model. Depletion of these proteins drastically reduced spontaneous and drug-induced latency reversal by suppressing HIV-1 transcriptional elongation. Surprisingly, a low-abundance subset of SECs containing ELL2 and AFF1 was found to play a predominant role in cooperating with Tat to reverse latency. By increasing the cellular level/activity of these Tat-friendly SECs, we could potently activate latent HIV-1 without using any drugs. These results implicate the ELL2/AFF1-SECs as an important target in the future design of a combinatorial therapeutic approach to purge latent HIV-1.
Funding Information
  • HHS | National Institutes of Health (R01AI095057)
  • HHS | U.S. Public Health Service (R01AI041757)

This publication has 36 references indexed in Scilit: